Book contents
- Parental Psychiatric DisorderDistressed Parents and Their FamiliesThird edition
- Parental Psychiatric Disorder
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 Fundamental issues
- Section 2 Comprehensive assessment
- Section 3 Specific disorders: the impact on children, parenting, and family relationships
- Section 4 Child, parent, and family interventions
- Chapter 19 Helping children understand their parent’s mental illness
- Chapter 20 Psychopharmacology and motherhood
- Chapter 21 Enhancing depressed mothers’ sensitivity
- Chapter 22 Working with parents who have a psychiatric disorder
- Chapter 23 Grandparents as primary caregivers
- Chapter 24 Interventions for families when a parent has depression
- Chapter 25 Creating positive parenting experiences: Family Options
- Section 5 Building workforce, organizational, and community capacity
- Index
- References
Chapter 20 - Psychopharmacology and motherhood
from Section 4 - Child, parent, and family interventions
Published online by Cambridge University Press: 05 July 2015
Book contents
- Parental Psychiatric DisorderDistressed Parents and Their FamiliesThird edition
- Parental Psychiatric Disorder
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 Fundamental issues
- Section 2 Comprehensive assessment
- Section 3 Specific disorders: the impact on children, parenting, and family relationships
- Section 4 Child, parent, and family interventions
- Chapter 19 Helping children understand their parent’s mental illness
- Chapter 20 Psychopharmacology and motherhood
- Chapter 21 Enhancing depressed mothers’ sensitivity
- Chapter 22 Working with parents who have a psychiatric disorder
- Chapter 23 Grandparents as primary caregivers
- Chapter 24 Interventions for families when a parent has depression
- Chapter 25 Creating positive parenting experiences: Family Options
- Section 5 Building workforce, organizational, and community capacity
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Parental Psychiatric DisorderDistressed Parents and their Families, pp. 210 - 222Publisher: Cambridge University PressPrint publication year: 2015
References
Abel, K. M. (2013). Fetal antipsychotic exposure in a changing landscape: seeing the future. British Journal of Psychiatry, 202, 321–3.Google Scholar
Adams, J., Lui, C.-W., Sibbritt, D., et al. (2009). Women’s use of complementary and alternative medicine during pregnancy: a critical review of the literature. Birth, 36, 237–45.Google Scholar
Bellantuono, C., Tofani, S., Di Sciascio, G., et al. (2013). Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. General Hospital Psychiatry, 35, 3–8.Google Scholar
Black, R. A., and Hill, D. A. (2003). Over-the-counter medications in pregnancy. American Family Physician, 67, 2517.Google Scholar
Bodén, R., Lundgren, M., Brandt, L., et al. (2012). Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Archives of General Psychiatry, 69, 715–21.Google Scholar
Buchanan, T. A., and Xiang, A. H. (2005). Gestational diabetes mellitus. Journal of Clinical Investigation, 115, 485–91.Google Scholar
Budzynska, K., Gardner, Z. E., Dugoua, J. J., et al. (2012). Systematic review of breastfeeding and herbs. Breastfeeding Medicine, 7, 489–503.Google Scholar
Byatt, N., Deligiannidis, K. M., and Freeman, M. P. (2013). Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatrica Scandinavica, 127, 94–114.Google Scholar
Clark, C. T., Klein, A. M., Perel, J. M., et al. (2013). Lamotrigine dosing for pregnant patients with bipolar disorder. American Journal of Psychiatry, 170, 1240–7.CrossRefGoogle ScholarPubMed
Clifton, V. L. (2010). Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta, 31 (Suppl), S33-9.CrossRefGoogle ScholarPubMed
Cohen, A., McCubbin, D. M., Collin, J., et al. (2001). Medications as social phenomena. Health, 5, 441–69.Google Scholar
Davanzo, R., Copertino, M., De Cunto, A., et al. (2011). Antidepressant drugs and breastfeeding: a review of the literature. Breastfeeding Medicine, 6, 89–98.Google Scholar
Dayan, J., Graignic-Philippe, R., Seligmann, C., et al. (2011). Use of antipsychotics and breastfeeding. Current Women’s Health Reviews, 7, 37–45.Google Scholar
Einarson, A., and Boskovic, R. (2009). Use and safety of antipsychotic drugs during pregnancy. Journal of Psychiatric Practice, 15, 183–92.CrossRefGoogle ScholarPubMed
Engeland, A., Bjørge, T., Daltveit, A. K., et al. (2012). Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases. British Journal of Clinical Pharmacology, 75, 1134–41.Google Scholar
Facchinetti, F., Pedrielli, G., Benoni, G., et al. (2012). Herbal supplements in pregnancy: unexpected results from a multicentre study. Human Reproduction, 27, 3161–7.Google Scholar
Fortinguerra, F., Clavenna, A., and Bonati, M. (2009). Psychotropic drug use during breastfeeding: a review of the evidence. Pediatrics, 124, e547–56.Google Scholar
Fasouliotis, S. J., and Schenker, J. G. (2000). Maternal–fetal conflict. European Journal of Obstetrics & Gynecology and Reproductive Biology, 89, 101–7.Google Scholar
Galbally, M., Snellen, M., Walker, S., et al. (2010). Management of antipsychotic and mood stabilizer medication in pregnancy; recommendations for antenatal care. Australian & New Zealand Journal of Psychiatry, 44, 99–108.CrossRefGoogle ScholarPubMed
Gentile, S. (2008). Infant safety with antipsychotic therapy in breast feeding: a systematic review. Journal of Clinical Psychiatry, 69, 666–73.Google Scholar
Gentile, S. (2010). Antipsychotic therapy during early and late pregnancy: a systematic review. Schizophrenia Bulletin, 36, 518–44.Google Scholar
Graves, J. A. (2010). Review: sex chromosome evolution and the expression of sex-specific genes in the placenta. Placenta, 31 (Suppl), S27–32.Google Scholar
Gurung, R. A. R. (2013). A multicultural approach to health psychology. American Journal of Lifestyle Medicine, 7, 4–12.Google Scholar
Higginbottom, G. M. A., Safipour, J., Mumtaz, Z., et al. (2013). “I have to do what I believe”: Sudanese women’s beliefs and resistance to hegemonic practices at home and during experiences of maternity care in Canada. BMC Pregnancy and Childbirth, 13(51).Google Scholar
Howard, L. M., Goss, C., Leese, M., et al. (2004). The psychosocial outcome of pregnancy in women with psychotic disorders. Schizophrenia Research, 71, 49–60.Google Scholar
Isoherranen, N., and Thummel, K. E. (2013). Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug Metabolism and Disposition, 41, 256–62.Google Scholar
Jensen, T. B., Gerds, T. A., Grøn, R., et al. (2013). Risk factors for venous thromboembolism during pregnancy. Pharmacoepidemiology and Drug Safety, 22, 1283–91.Google Scholar
La Torre, D., and Falorni, A. (2007). Pharmacological causes of hyperprolactinemia. Therapeutic Clinical Risk Management, 3, 929–51.Google Scholar
Le Houezec, J., and Aubin, H. J. (2013). Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence. Expert Opinion on Pharmacotherapy, 14, 1959–67.Google Scholar
Lin, H. C., Chen, I. J., Chen, Y. H., et al. (2010). Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference? Schizophrenia Research, 116, 55–60.Google Scholar
Louik, C., Gardiner, P., Kelley, K., et al. (2010). Use of herbal treatments in pregnancy. American Journal of Obstetrics and Gynecology, 202, 439 e1–10.Google Scholar
Malek, A., and Mattison, D. R. (2010). Drug development for use during pregnancy: impact of the placenta. Expert Review of Obstetrics and Gynecology, 5, 437–54.Google Scholar
McKean, M. (2013). Psychiatric care during pregnancy and postpartum. II. Management of anxiety, psychosis, and lactation. Psychopharm Review, 48, 25–31.Google Scholar
McNeil, T. F., Kaij, L., and Maimquist-Larsson, A. (1984). Women with nonorganic psychosis: pregnancy’s effect on mental health during pregnancy. Acta Psychiatrica Scandinavica, 70, 140–8.Google Scholar
Morrow, J., Russell, A., Guthrie, E., et al. (2006). Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. Journal of Neurology, Neurosurgery and Psychiatry, 77, 193–8.Google Scholar
Murphy, E., and McMahon, F. J. (2013). Pharmacogenetics of antidepressants, mood stabilizers, and antipsychotics in diverse human populations. Discovery Medicine, 16, 113–22.Google Scholar
Oesterheld, J. R., Cozza, K., and Sandson, N. B. (2008). Oral contraceptives. Psychosomatics, 49, 168–75.Google Scholar
Peters, S., Lind, J. L., Humphrey, J. R., et al. (2013). Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011. Pharmacoepidemiology and Drug Safety, 22, 324–8.Google Scholar
Sachs, H. C., and Committee on Drugs (2013). The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics, 132, e797–e809.Google Scholar
Sadowski, A., Todorow, M., Brojeni, P. Y., et al. (2013). Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study. BMJ Open, 3, e003062.Google Scholar
Seeman, M. V. (2012). Antipsychotic-induced somnolence in mothers with schizophrenia. Psychiatric Quarterly, 83, 83–9.Google Scholar
Seeman, M. V., and Ross, R. (2011). Prescribing contraceptives for women with schizophrenia. Journal of Psychiatric Practice, 17, 258–69.Google Scholar
Seeman, M. V., and Seeman, N. (2012). The meaning of antipsychotic medication to patients with schizophrenia. Journal of Psychiatric Practice, 18, 338–48.CrossRefGoogle ScholarPubMed
US Food and Drug Administration (2011). Washington, DC (www.fda.gov/Drugs/DrugSafety/ucm243903.htm#list).Google Scholar
van der Geest, S., Whyte, S. R., and Hardon, A. (1996). Anthropology of pharmaceuticals: a biographical approach. Annual Review of Anthropology, 25, 153–78.Google Scholar
Vemuri, M., and Williams, K. (2011). Treating bipolar disorder during pregnancy: optimal outcomes require careful preconception planning, medication risk/benefit analysis. Current Psychiatry, 10, 58–66.Google Scholar
Werler, M. M., Mitchell, A. A., Hernandez-Diaz, S., et al. (2005). Use of over-the-counter medications during pregnancy. American Journal of Obstetrics and Gynecology, 193, 771–7.Google Scholar
Wichman, C. L. (2009). Atypical antipsychotic use in pregnancy: a retrospective review. Archives of Women’s Mental Health, 12, 53–7.Google Scholar
Wilkie, M. J. V., Smith, G., Day, R. K., et al. (2009). Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy. Pharmacogenomics Journal, 9, 61–70.CrossRefGoogle ScholarPubMed
Yonkers, K. A., Vigod, S., and Ross, L. E. (2011). Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstetrics and Gynecology, 117, 961–77.CrossRefGoogle ScholarPubMed
Yonkers, K. A., Wisner, K. L., Stowe, Z., et al. (2004). Management of bipolar disorder during pregnancy and the postpartum period. American Journal of Psychiatry, 161, 608–20.Google Scholar
- 1
- Cited by